Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DGAT1 | O75907 | 8/20 | 0.55 |
| ▸ | KCNH2 | Q12809 | 6/20 | 0.55 |
| ▸ | NPBWR1 | P48145 | 8/20 | 0.54 |
| ▸ | KDR | P35968 | 3/20 | 0.50 |
| ▸ | MET | P08581 | 1/20 | 0.50 |
| ▸ | KIT | P10721 | 1/20 | 0.47 |
| ▸ | SOAT1 | P35610 | 3/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31592851 | 1.00 | DGAT1 (0.55) | DGAT1KCNH2NPBWR1KDRMET | |
| SCHEMBL31593020 | 0.92 | DGAT1 (0.66) | DGAT1KCNH2NPBWR1KDRSOAT1 | |
| SCHEMBL31592941 | 0.89 | DGAT1 (0.54) | DGAT1KCNH2NPBWR1KDRKIT | |
| SCHEMBL31592917 | 0.89 | NPBWR1 (0.55) | DGAT1KCNH2NPBWR1KDRMET | |
| SCHEMBL31593053 | 0.87 | CBFB (0.60) | DGAT1KCNH2NPBWR1KDRKIT | |
| SCHEMBL31593000 | 0.85 | DGAT1 (0.52) | DGAT1KCNH2NPBWR1KDRKIT | |
| SCHEMBL31592791 | 0.85 | DGAT1 (0.60) | DGAT1KCNH2NPBWR1KDRKIT | |
| SCHEMBL27040042 | 0.81 | DGAT1 (0.64) | DGAT1KCNH2NPBWR1KDRKIT | |
| SCHEMBL31592990 | 0.81 | DGAT1 (0.64) | DGAT1KCNH2NPBWR1KDRKIT | |
| SCHEMBL31592861 | 0.81 | DGAT1 (0.53) | DGAT1KCNH2NPBWR1KDRMET |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4559908-A1 | HETEROARYL DERIVATIVE COMPOUND AND USE THEREOF | S2CBio Inc. (KR) | 2025-05-28 | — | — | EP | disclosed |
| WO-2024058617-A1 | ANTIVIRAL USE OF HETEROARYL DERIVATIVE COMPOUND | 일동제약(주) | 2024-03-21 | — | — | WO | disclosed |
| WO-2024019541-A1 | HETEROARYL DERIVATIVE COMPOUND AND USE THEREOF | 일동제약(주) | 2024-01-25 | — | — | WO | disclosed |
| WO-2024019541-A1 | HETEROARYL DERIVATIVE COMPOUND AND USE THEREOF | 일동제약(주) | 2024-01-25 | — | — | WO | disclosed |